DEA, HHS delay telehealth buprenorphine prescribing rule again

Healthcare DIVE March 21, 2025
Emily Olsen

The final rule, which allows registered clinicians to prescribe up to an initial six-month supply of the drug used to treat opioid use disorder via telehealth, will now go into effect Dec. 31.

Dive Brief:

• The Drug Enforcement Administration and the HHS have delayed a final rule expanding telehealth prescriptions of a drug that treats opioid use disorder for a second time.
• The agencies pushed back enforcement of the rule, which allows DEA-registered clinicians to prescribe up to an initial six-month supply of buprenorphine via telehealth without first seeing the patient in person, to Dec. 31.
• They also delayed another regulation that permits providers at the Department of Veterans Affairs to prescribe controlled substances without conducting an in-person evaluation...

Today's Sponsors

Today's Sponsor